Century Therapeutics furnishes updated investor presentation; no specific new financial or pipeline details disclosed

Century Therapeutics, Inc.

Filing under Item 7.01 includes an investor presentation dated March 20, 2023, used in meetings with investors.
The presentation content is not fully disclosed; no earnings, pipeline, or corporate changes are specified.
No material new information can be extracted from the filing text or the limited exhibit excerpt provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.